Dorzolamide HCl and Timolol Maleate Ophthalmic Solution — Class II drug recall D-0730-2026
Ongoing recall by MICRO LABS USA INC, reported 2026-08-05, distributed nationwide. Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
| Recall number | D-0730-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | MICRO LABS USA INC, Somerset, NJ, United States |
| Recall initiated | 2026-07-22 |
| Classified | 2026-07-24 |
| Reported by FDA | 2026-08-05 |
| Distributed | Nationwide (US) |
| Reason classes | packaging |
| NDC | 42571-0147, 42571-0147-26 |
| Lot numbers | DLHU0031 |
| Expiration dates | 2027-06-30 |
Product
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.
Reason for recall
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0730-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.